[TimAlerts] $PBYI halted potential reversal

[TimAlerts] $PBYI https://twitter.com/adamfeuerstein/status/781830313479589890

[TimAlerts] $PBYI Citi analyst Yigal Nochomovitz views this morning's news that the FDA accepted Puma Biotechnology's New Drug Application for its lead product candidate PB272 as "perhaps the biggest derisking event" in the company's history. A broader set of investors could be inclined to take a position in the name now, Nochomovitz tells investors in a research note. The analyst recommends buying Puma shares on the news. He expects neratinib to be approved by the FDA next summer and expects the stock to b

[TimAlerts] I'm going to change my opinion of $PBYI news -- I'm not sure why, but I must be wrong on that; I won't trade it

[TimAlerts] Meg Tirrell @megtirrell $PBYI up 7.3% pre-market as FDA accepts New Drug Application -- what Citi calls "perhaps biggest derisking event in Puma's history"

[TimAlerts] $PBYI http://finance.yahoo.com/news/puma-biotechnology-announces-u-fda-120100279.html "Puma Biotechnology Announces U.S. FDA Acceptance of New Drug Application for PB272 (Neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer" -- not very important news -- just means they filled out paperwork correctly

[TimAlerts] $PBYI

[TimAlerts] $PBYI resumes

[TimAlerts] $PBYI volatility halt

[TimAlerts] first trade $PBYI in @ $28.83 out @ $29.83